Patrick Taylor is an Assistant Clinical Professor at Harvard Medical School, and a Staff Scientist and Director of Ethics Analysis and Applications at Children's Hospital Boston, where he was also, until recently, Deputy General Counsel and Chief Counsel for Research Affairs. Patrick Taylor holds a B.A. in Zoology and Philosophy from the University of Wisconsin-Madison, where he graduated with distinction, was included on the Dean’s List, and was invited to join Phi Beta Kappa based on his academic achievements. In 1986, he obtained his J.D. from Columbia University Law School, and was honored as a Harlan Fiske Stone Scholar. Patrick Taylor’s postdoctoral education includes Harvard’s Bioethics program and Fellowship in Medical Ethics via the Medical School Department of Social Medicine, and the Leadership Development program through the Harvard Business School.Patrick Taylor has written about a wide range of subjects, including development of clinical networks, intellectual-property ethics, stem-cell research, disparate interests in biomedical research, and the public’s role in making policy for the scientific arena. His writings have been featured in such publications as Cell Stem Cell, Drug Development, The American Bar Association’s Health Lawyer, Nature, Science Translational Medicine, Science and Engineering Ethics, Cell, and the Journal of the New York State Bar Association.Patrick Taylor’s detailed research and scholarship has made a significant contribution in policy-making for biomedical research, pediatric health records, and the potential conflicts of interest at the intersection of academia and industry. Patrick Taylor was a professional member of the Health Section of the New York State Bar Association, where he acted as Chair of the In-House Counsel Committee, Vice-Chair of the Legislation Committee, and Member of the Executive Committee. He also served as Co-Chair of the Standards Committee, Chair of the Registry Committee, Member of the Ethics and Public Policy Committee, Member of the Task Force on Guidelines for Conduct of Human Embryonic Stem Cell Research, and Member of the Task Force on Clinical Translation of Stem Cells for the International Society for Stem Cell Research (ISSCR).